CNBX Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Bethesda, MD
SEC filing record 1 source field available
Fiscal year end
31 August
CNBX Pharmaceuticals Inc. has filed 300 SEC EDGAR filings since 09 Jan 2006

SEC filing history

Showing 1-25 of 60 matching filings.

Per page
25
Current page
1
10-Q File 000-52403

FORM 10-Q FOR MAY 2026

Filing date
24 Jun 2026
Reporting date
31 May 2026
Next action
Verify source filing
10-Q File 000-52403

QUARTERLY REPORT

Filing date
14 Jan 2026
Reporting date
30 Nov 2025
Next action
Verify source filing
10-Q File 000-52403

FORM 10-Q FOR NOV 2024

Filing date
13 Jan 2025
Reporting date
30 Nov 2024
Next action
Verify source filing
10-Q File 000-52403

FORM 10-Q FOR FEBRUARY 2024

Filing date
16 Apr 2024
Reporting date
29 Feb 2024
Next action
Verify source filing
10-Q File 000-52403

QUARTERLY REPORT

Filing date
12 Jan 2024
Reporting date
30 Nov 2023
Next action
Verify source filing
10-Q File 000-52403

QUARTERLY REPORT

Filing date
14 Jul 2023
Reporting date
31 May 2023
Next action
Verify source filing
10-Q File 000-52403

QUARTERLY REPORT

Filing date
14 Apr 2023
Reporting date
28 Feb 2023
Next action
Verify source filing
10-Q File 000-52403

QUARTERLY REPORT

Filing date
14 Apr 2021
Reporting date
28 Feb 2021
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .